Clinical Trial Update: Study to Assess the Efficacy and Safety of Allogeneic Osteoblastic Cells (ALLOB®) Single Implantation in Tibial Fracture [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of ALLOB single implantation for tibial fracture.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tibial Fracture

Drugs mentioned

• ALLOB

Snippet

Sponsor: Bone Therapeutics S.A | Conditions: Tibial Fracture | Phase 2 | Status: UNKNOWN